In a new Yale-led study, investigators have revealed previously unknown factors that contribute to the hardening of arteries and plaque growth, which cause heart disease. Their insight is the basis for a promising therapeutic approach to halt and potentially reverse plaque buildup and the progression of disease, the researchers said.
Current treatments for plaque and hardened arteries, a condition known as atherosclerosis, can slow but not improve the disease. Experts believe that may be due to ongoing inflammation in blood vessels. To understand the factors contributing to this inflammation, the research team focused on a group of proteins, called transforming growth factor beta (TGFß), that regulates a wide range of cells and tissues throughout the body.
Using cultured human cells, the researchers discovered that TGF? proteins trigger inflammation in endothelial cells — the cells that form the inner lining of artery walls — but not in other cell types. With a technique called single cell RNA-seq analysis, which measures the expression of every gene in single cells, they then showed that TGF? induced inflammation in these cells in mouse models. This finding was notable, said the researchers, because TGF? proteins are known to decrease inflammation in other cells in the body.
The researchers also showed that when the TGF? receptor gene is deleted in endothelial cells, both the inflammation and plaque in blood vessels are significantly reduced.
To test this approach as a potential therapy, the team, led by professor of medicine Michael Simons, M.D., used an “interfering” RNA, or RNAi, drug developed at Yale, to disrupt TGFß receptors. Interfering RNA use a gene’s own DNA sequence to turn off or silence the gene. To deliver the drug only to endothelial cells in the blood vessel walls of mice, they employed microscopic particles, or nanoparticles, created by their co-authors at MIT. This strategy reduced inflammation and plaque as effectively as the genetic technique.
The findings identify TGFß signaling as a major cause of chronic vessel wall inflammation, and demonstrate that disruption of this pathway leads to cessation of inflammation and substantial regression of existing plaque, said the scientists.
Based on this discovery, investigators at Yale and MIT have launched a biotech company, VasoRX, Inc., to develop this targeted approach, using the RNAi drug delivered by nanoparticles as a potential therapy for atherosclerosis in people.
The Latest on: Atherosclerosis
[google_news title=”” keyword=”atherosclerosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Atherosclerosis
- Patients with primary Sjogren's syndrome more likely to develop subclinical atherosclerosison December 1, 2023 at 3:30 am
Patients with primary Sjogren's syndrome more likely to develop subclinical atherosclerosis than control group suggests a new study published in the European Journal of Internal ...
- The cholesterol controversyon November 30, 2023 at 6:17 pm
The role of cholesterol in the development of atherosclerosis and cardiovascular disease is still marred in controversy and shrouded in statistical mystery.
- Tirzepatide Reduces 10-Year Atherosclerosis Risk Among Patients With Obesityon November 29, 2023 at 3:59 pm
Tirzepatide was linked to improved risk for atherosclerosis among patients with obesity. Tirzepatide treatment is associated with a significant reduction in 10-year risk for atherosclerosis among ...
- Regression of Coronary Atherosclerosis by Simvastatinon November 27, 2023 at 4:00 pm
Progression of coronary atherosclerosis may lead to angina pectoris, acute coronary syndromes, or death for cardiac reasons, all of which are frequent causes of mortality and morbidity in the western ...
- Role of Endothelial Dysfunction in Atherosclerosison November 27, 2023 at 4:00 pm
From the Hyperlipidemia and Atherosclerosis Research Group/Groupe de recherche sur les hyperlipidémies et l’athérosclérose, Clinical Research Institute of Montreal/Institut de recherches cliniques de ...
- New Research Indicates That Atherosclerosis – Thought To Be Irreversible – Can Be Reversedon November 27, 2023 at 3:33 am
Younger individuals are at a higher risk of experiencing the adverse cardiovascular effects associated with elevated blood cholesterol and hypertension. Younger individuals might be more vulnerable to ...
- Is there a link between MS and atherosclerosis?on November 26, 2023 at 4:01 pm
Atherosclerosis is a cardiovascular condition that occurs when plaque progressively blocks arteries. MS can cause numbness, pain, and several motor and neurological problems. There’s no cure for ...
- Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age Peopleon November 22, 2023 at 8:32 am
Younger people seem to have the most to gain from lowering lipids and BP, suggesting very early treatment is worth exploring.
- 'Silent Atherosclerosis' Can Be Especially Deadly for Young People, Study Findson November 20, 2023 at 6:25 am
Atherosclerosis can lead to stroke, heart attack, and heart failure. Adults as young as 20 should have regular physicals and monitor their blood pressure and cholesterol levels to assess any future ...
- Atherosclerosis: Symptoms, Causes, and Preventionon November 6, 2023 at 4:01 pm
Atherosclerosis is when plaque -- a sticky substance made of cholesterol, fat, calcium, and other materials — builds up inside the walls of your arteries. Arteries are the blood vessels that ...
via Bing News